Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

BiO2 Medical brings in $12mm through its Series C venture round

Executive Summary

Respiratory and cardiovascular device developer BiO2 Medical Inc. has raised $12mm through its Series C venture round. Remeditex Ventures led the financing and was joined by 29 of the company’s current shareholders. The money will be used to market the Angel central venous catheter and inferior vena cava filter combination device, which reduces the risk of pulmonary embolism in critically ill patients.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies